fbpx
Regeneron's Monoclonal antibodies for treatment of COVID-19 Coronavirus Approved by FDA

ERG Clinical Trial Sites Contribute to Approval of Regeneron’s COVID-19 Treatment

With COVID-19 cases rising at alarming rates across the US, Emergency Use Authorization of Regeneron’s COVID treatment couldn’t have come soon enough.  The FDA announced late last month that casirivimab and imdevimab, two monoclonal antibodies, were authorized for emergency use in patients with mild and moderate Coronavirus Disease 2019. Clinical trials demonstrated that the two …

Read moreERG Clinical Trial Sites Contribute to Approval of Regeneron’s COVID-19 Treatment

Diversity in San Antonio: COVID-19 Clinical Trials

Check out this interview of Dr. Sherwyn Schwartz at Endeavor Clinical Trials regarding our mission to unite against COVID-19 in the San Antonio area. At Endeavor Clinical Trials, we’re committed to ensuring those who participate in a clinical trial are as diverse as the community that needs medical treatments, medications, or benefits from the advancement …

Read moreDiversity in San Antonio: COVID-19 Clinical Trials

The Sad Truth About COVID-19 and Schizophrenia

As the World Health Organization (WHO) and governments scramble to flatten the curve of COVID-19, a one-size-fits-all approach has been taken with the general populace. For those in certain marginalized groups such as individuals with schizophrenia and other related disorders, these strategies may be less effective. Schizophrenia can be unpredictable in the best of times, …

Read moreThe Sad Truth About COVID-19 and Schizophrenia

Mental Health Awareness Month

May is Mental Health Awareness Month. Nearly 1 in 5 adults will have a diagnosable mental health condition in any given year. Yet, 56% of adults with mental illness do not receive treatment. Amid COVID-19 and preparations being made to reopen the country, the timing couldn’t be more perfect. Mental Health Awareness Month Mental Health …

Read moreMental Health Awareness Month

COVID-19 INFO

The health of our staff members, study participants and visitors is of the utmost importance to us.